Halladay Benjamin (CIK 0001953943)

Latest company ownership

Shares held
474,862
Last filed at
Sep 18, 2025
Confidence Score
27.1
2025Q4
Confidence Score History
2024Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 17, 2025 Dec 18, 2025 Esperion Therapeutics, Inc. CFO Sell 26.3 -7,337 -1.55% ✗ $26.9K
Sep 17, 2025 Sep 18, 2025 Esperion Therapeutics, Inc. CFO Sell 26.3 -7,046 -1.46% ✗ $19.8K
Jul 17, 2025 Jul 18, 2025 Esperion Therapeutics, Inc. CFO Sell 52.5 -11 0.00% ✗ $12.3
Jun 17, 2025 Jun 18, 2025 Esperion Therapeutics, Inc. CFO Sell 27.5 -7,229 -1.50% ✗ $8.3K
Apr 17, 2025 Apr 21, 2025 Esperion Therapeutics, Inc. CFO Sell 52.5 -8 0.00% ✗ $7.7
Mar 18, 2025 Mar 19, 2025 Esperion Therapeutics, Inc. CFO Sell 37.5 -3,535 -0.73% ✗ $5.2K
Feb 19, 2025 Feb 20, 2025 Esperion Therapeutics, Inc. CFO Sell 52.5 -11 0.00% ✗ $20.5
Jan 17, 2025 Jan 21, 2025 Esperion Therapeutics, Inc. CFO Sell 52.5 -9 0.00% ✗ $20.4
Dec 17, 2024 Dec 18, 2024 Esperion Therapeutics, Inc. CFO Sell 27.5 -3,245 -1.33% ✗ $7.9K